Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance (MGUS)

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance (MGUS). Study availability and eligibility vary by location and protocol.

9 public trials 6 recruiting studies

Monoclonal Gammopathy of Undetermined Significance (MGUS) trial results

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Health Ann Arbor, Michigan, United States
  • NYU Langone Health Perlmutter Cancer Center New York, United States
View all 39 locations
Conditions
B-cell Malignancy, Low-grade, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute at St. Elizabeth's Brighton, Massachusetts, United States
  • Dana Farber Cancer Institute at Merrimack Valley Methuen, Massachusetts, United States
  • Dana Farber Cancer Institute at Milford Regional Medical Center Milford, Massachusetts, United States
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • Istituto Ortopedico Rizzoli IRCCS Bologna, Italy
  • UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco" Catania, Italy
  • UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone" Palermo, Italy
  • S.C Ematologia - Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy